Literature DB >> 25376668

Treatment with haemodiafiltration stabilises vascular stiffness (measured by aortic pulse wave velocity) compared to haemodialysis.

Evangelia Charitaki1, Daniel Belman, Andrew Davenport.   

Abstract

BACKGROUND/AIMS: Cerebrovascular diseases such as stroke are increased in dialysis patients, and haemodiafiltration has been reported to reduce cerebrovascular mortality compared to haemodialysis. We wished to determine whether haemodiafiltration improves arterial stiffness.
METHODS: We audited aortic pulse wave velocity (PWV) measurements 6 months apart in 3 cohorts of patients: 69 treated with haemodialysis, 78 who converted from haemodialysis to haemodiafiltration and 142 treated with haemodiafiltration.
RESULTS: Cohorts were well matched for age (means ± SD: haemodialysis 64 ± 15 years vs. haemodialysis to haemodiafiltration 64 ± 17 years vs. haemodiafiltration 67 ± 16 years), sex (male 65 vs. 59 vs. 63%), diabetes (45 vs. 56.4 vs. 44%) and body mass index (26 ± 6 vs. 26 ± 5 vs. 26 ± 5), respectively. Systolic blood pressure did not differ over time (haemodialysis 143 ± 25 vs. 146 ± 27 mm Hg, haemodialysis to haemodiafiltration 153 ± 26 vs. 154 ± 25 mm Hg, haemodiafiltration 149 ± 31 vs. 148 ± 30 mm Hg) or between groups. Aortic PWV significantly increased in the haemodialysis group (9.5 ± 1.9 vs. 10.2 ± 2.2 m/s, p < 0.01) and haemodialysis to haemodiafiltration group (9.4 ± 1.9 vs. 10.1 ± 2.2 m/s, p < 0.01), but did not change with haemodiafiltration (9.9 ± 2.1 vs. 10.1 ± 2.2 m/s).
CONCLUSIONS: Aortic PWV, a measure of vascular stiffness, stabilised with haemodiafiltration. Our preliminary findings require further investigation to determine how haemodiafiltration may potentially improve vascular stiffness.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25376668     DOI: 10.1159/000368242

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  2 in total

1.  Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.

Authors:  Rukshana Shroff; Colette Smith; Bruno Ranchin; Aysun K Bayazit; Constantinos J Stefanidis; Varvara Askiti; Karolis Azukaitis; Nur Canpolat; Ayşe Ağbaş; Helen Aitkenhead; Ali Anarat; Bilal Aoun; Daley Aofolaju; Sevcan Azime Bakkaloglu; Devina Bhowruth; Dagmara Borzych-Dużałka; Ipek Kaplan Bulut; Rainer Büscher; John Deanfield; Claire Dempster; Ali Duzova; Sandra Habbig; Wesley Hayes; Shivram Hegde; Saoussen Krid; Christoph Licht; Mieczyslaw Litwin; Mark Mayes; Sevgi Mir; Rose Nemec; Lukasz Obrycki; Fabio Paglialonga; Stefano Picca; Charlotte Samaille; Mohan Shenoy; Manish D Sinha; Brankica Spasojevic; Lynsey Stronach; Enrico Vidal; Karel Vondrák; Alev Yilmaz; Ariane Zaloszyc; Michel Fischbach; Claus Peter Schmitt; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2019-03-07       Impact factor: 10.121

2.  High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.

Authors:  Marijke Dekker; Andreas Pasch; Frank van der Sande; Constantijn Konings; Matthias Bachtler; Mauro Dionisi; Matthias Meier; Jeroen Kooman; Bernard Canaud
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.